AILA BIOTECH LTD
Opportunity 71/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (58/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-10-31 | 2024-10-31 |
|---|
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
2 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 5 persons-with-significant-control
- • 2 capital
- • 5 persons-with-significant-control
- • 2 capital
Corporate timeline (15 events)Click to expand
- 2026-05-05📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2026-05-05📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2026-05-05📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2026-05-05📄capital-allotment-sharescapital · SH01
- 2026-04-19📄capital-allotment-sharescapital · SH01
- 2026-04-05📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2026-04-05📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2025-12-19📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-12-12📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-10-27📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2023-11-17📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-06-12📄accounts-with-accounts-type-dormantaccounts · AA
- 2021-10-13🏢Company incorporatedAs AILA BIOTECH LTD
- 2021-10-13➕LISTON, Adrian, Dr appointeddirector
- 2021-10-13📄incorporation-companyincorporation · NEWINC
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Sole director: Only one active director — all governance concentrated on one person.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
3 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Prof James Louis Dooley Individual · Belgian,American · DOB 09/1970 · age 56 | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 01/01/2025 |
Prof Matthew Holt Individual · Belgian,British · DOB 10/1974 · age 52 | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 01/01/2025 |
Dr Adrian Liston Individual · British,Belgian · DOB 04/1980 · age 46 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 13/10/2021 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Professional services · CB postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| AELORA LIMITED→ 16696506 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AGF CONSULTING LTD→ 10860265 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| AGFEC CONSULTING LTD→ 13753335 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| AGNOTIS CARE PRODUCTS CO., LTD→ 12461826 · est 2020 · no financials extracted | — | — | — | — | 6y | — | — |
| AGRETHOS LTD→ 12493090 · est 2020 · no financials extracted | — | — | — | — | 6y | — | — |
| AGUILA RISK MANAGEMENT LIMITED→ 16454553 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AGUILA RISK SERVICES LIMITED→ 16457351 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AH ASSET MANAGEMENT LIMITED→ 15405228 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| AI & HUMAN EMPOWERMENT CIC→ 16836393 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AIMAX AXIS LIMITED→ 16937969 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AIME CONSULTING LTD→ 10037474 · est 2016 · no financials extracted | — | — | — | — | 10y | — | — |
| AIPOLAS LIMITED→ 08239081 · est 2012 · no financials extracted | — | — | — | — | 13y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.